The validation of the Italian version of multiple sclerosis neuropsychological screening questionnaire in Huntington’s disease
Introduction Multiple sclerosis neuropsychological questionnaire (MSNQ) is a brief questionnaire useful for screening patient’s and informant’s self-perception of cognitive dysfunctions in daily life activities. Our study aims to evaluate the MSNQ validity in Huntington’s disease (HD) mutation carri...
Saved in:
Published in | Neurological sciences Vol. 44; no. 12; pp. 4343 - 4348 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.12.2023
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction
Multiple sclerosis neuropsychological questionnaire (MSNQ) is a brief questionnaire useful for screening patient’s and informant’s self-perception of cognitive dysfunctions in daily life activities. Our study aims to evaluate the MSNQ validity in Huntington’s disease (HD) mutation carriers and to correlate MSNQ scores with neurological, cognitive, and behavioral variables.
Methods
The study was conducted on a sample of 107 subjects from presymptomatic to the middle stage of HD recruited at LIRH Foundation and C.S.S. Mendel Institute in Rome. Unified Huntington’s Disease Rating Scale (UHDRS), an internationally standardized and validated scale, was used to evaluate motor, functional cognitive, and behavioral domains.
Results
Our results showed that in HD subjects, MSNQ has a unidimensional factor structure. Correlational analyses indicated a good correlation between the MSNQ-patient version (MSNQ-p) and clinical variables, specifically with cognitive dysfunction and behavioral alterations. Moreover, higher scores in MSNQ-p were associated with higher motor disease and functional impairment showing that patients in advanced stage of HD perceive a greater cognitive impairment. These results confirm the questionnaire’s reliability.
Conclusions
The present study demonstrates the validity and adaptability of MSNQ in the HD population proposing it as a cognitive tool during routine clinical follow-ups, although further research is needed to determine an optimal cut-off score for this measure. |
---|---|
AbstractList | Multiple sclerosis neuropsychological questionnaire (MSNQ) is a brief questionnaire useful for screening patient's and informant's self-perception of cognitive dysfunctions in daily life activities. Our study aims to evaluate the MSNQ validity in Huntington's disease (HD) mutation carriers and to correlate MSNQ scores with neurological, cognitive, and behavioral variables.INTRODUCTIONMultiple sclerosis neuropsychological questionnaire (MSNQ) is a brief questionnaire useful for screening patient's and informant's self-perception of cognitive dysfunctions in daily life activities. Our study aims to evaluate the MSNQ validity in Huntington's disease (HD) mutation carriers and to correlate MSNQ scores with neurological, cognitive, and behavioral variables.The study was conducted on a sample of 107 subjects from presymptomatic to the middle stage of HD recruited at LIRH Foundation and C.S.S. Mendel Institute in Rome. Unified Huntington's Disease Rating Scale (UHDRS), an internationally standardized and validated scale, was used to evaluate motor, functional cognitive, and behavioral domains.METHODSThe study was conducted on a sample of 107 subjects from presymptomatic to the middle stage of HD recruited at LIRH Foundation and C.S.S. Mendel Institute in Rome. Unified Huntington's Disease Rating Scale (UHDRS), an internationally standardized and validated scale, was used to evaluate motor, functional cognitive, and behavioral domains.Our results showed that in HD subjects, MSNQ has a unidimensional factor structure. Correlational analyses indicated a good correlation between the MSNQ-patient version (MSNQ-p) and clinical variables, specifically with cognitive dysfunction and behavioral alterations. Moreover, higher scores in MSNQ-p were associated with higher motor disease and functional impairment showing that patients in advanced stage of HD perceive a greater cognitive impairment. These results confirm the questionnaire's reliability.RESULTSOur results showed that in HD subjects, MSNQ has a unidimensional factor structure. Correlational analyses indicated a good correlation between the MSNQ-patient version (MSNQ-p) and clinical variables, specifically with cognitive dysfunction and behavioral alterations. Moreover, higher scores in MSNQ-p were associated with higher motor disease and functional impairment showing that patients in advanced stage of HD perceive a greater cognitive impairment. These results confirm the questionnaire's reliability.The present study demonstrates the validity and adaptability of MSNQ in the HD population proposing it as a cognitive tool during routine clinical follow-ups, although further research is needed to determine an optimal cut-off score for this measure.CONCLUSIONSThe present study demonstrates the validity and adaptability of MSNQ in the HD population proposing it as a cognitive tool during routine clinical follow-ups, although further research is needed to determine an optimal cut-off score for this measure. IntroductionMultiple sclerosis neuropsychological questionnaire (MSNQ) is a brief questionnaire useful for screening patient’s and informant’s self-perception of cognitive dysfunctions in daily life activities. Our study aims to evaluate the MSNQ validity in Huntington’s disease (HD) mutation carriers and to correlate MSNQ scores with neurological, cognitive, and behavioral variables.MethodsThe study was conducted on a sample of 107 subjects from presymptomatic to the middle stage of HD recruited at LIRH Foundation and C.S.S. Mendel Institute in Rome. Unified Huntington’s Disease Rating Scale (UHDRS), an internationally standardized and validated scale, was used to evaluate motor, functional cognitive, and behavioral domains.ResultsOur results showed that in HD subjects, MSNQ has a unidimensional factor structure. Correlational analyses indicated a good correlation between the MSNQ-patient version (MSNQ-p) and clinical variables, specifically with cognitive dysfunction and behavioral alterations. Moreover, higher scores in MSNQ-p were associated with higher motor disease and functional impairment showing that patients in advanced stage of HD perceive a greater cognitive impairment. These results confirm the questionnaire’s reliability.ConclusionsThe present study demonstrates the validity and adaptability of MSNQ in the HD population proposing it as a cognitive tool during routine clinical follow-ups, although further research is needed to determine an optimal cut-off score for this measure. Multiple sclerosis neuropsychological questionnaire (MSNQ) is a brief questionnaire useful for screening patient's and informant's self-perception of cognitive dysfunctions in daily life activities. Our study aims to evaluate the MSNQ validity in Huntington's disease (HD) mutation carriers and to correlate MSNQ scores with neurological, cognitive, and behavioral variables. The study was conducted on a sample of 107 subjects from presymptomatic to the middle stage of HD recruited at LIRH Foundation and C.S.S. Mendel Institute in Rome. Unified Huntington's Disease Rating Scale (UHDRS), an internationally standardized and validated scale, was used to evaluate motor, functional cognitive, and behavioral domains. Our results showed that in HD subjects, MSNQ has a unidimensional factor structure. Correlational analyses indicated a good correlation between the MSNQ-patient version (MSNQ-p) and clinical variables, specifically with cognitive dysfunction and behavioral alterations. Moreover, higher scores in MSNQ-p were associated with higher motor disease and functional impairment showing that patients in advanced stage of HD perceive a greater cognitive impairment. These results confirm the questionnaire's reliability. The present study demonstrates the validity and adaptability of MSNQ in the HD population proposing it as a cognitive tool during routine clinical follow-ups, although further research is needed to determine an optimal cut-off score for this measure. Introduction Multiple sclerosis neuropsychological questionnaire (MSNQ) is a brief questionnaire useful for screening patient’s and informant’s self-perception of cognitive dysfunctions in daily life activities. Our study aims to evaluate the MSNQ validity in Huntington’s disease (HD) mutation carriers and to correlate MSNQ scores with neurological, cognitive, and behavioral variables. Methods The study was conducted on a sample of 107 subjects from presymptomatic to the middle stage of HD recruited at LIRH Foundation and C.S.S. Mendel Institute in Rome. Unified Huntington’s Disease Rating Scale (UHDRS), an internationally standardized and validated scale, was used to evaluate motor, functional cognitive, and behavioral domains. Results Our results showed that in HD subjects, MSNQ has a unidimensional factor structure. Correlational analyses indicated a good correlation between the MSNQ-patient version (MSNQ-p) and clinical variables, specifically with cognitive dysfunction and behavioral alterations. Moreover, higher scores in MSNQ-p were associated with higher motor disease and functional impairment showing that patients in advanced stage of HD perceive a greater cognitive impairment. These results confirm the questionnaire’s reliability. Conclusions The present study demonstrates the validity and adaptability of MSNQ in the HD population proposing it as a cognitive tool during routine clinical follow-ups, although further research is needed to determine an optimal cut-off score for this measure. |
Author | Ceccarelli, Consuelo D’Aurizio, Giulia Curcio, Giuseppe Squitieri, Ferdinando Migliore, Simone Casella, Melissa |
Author_xml | – sequence: 1 givenname: Simone orcidid: 0000-0002-2665-231X surname: Migliore fullname: Migliore, Simone email: sim.migliore@gmail.com organization: Huntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo Della Sofferenza Hospital – sequence: 2 givenname: Giulia surname: D’Aurizio fullname: D’Aurizio, Giulia organization: Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila – sequence: 3 givenname: Consuelo surname: Ceccarelli fullname: Ceccarelli, Consuelo organization: Italian League for Research On Huntington (LIRH) Foundation – sequence: 4 givenname: Melissa surname: Casella fullname: Casella, Melissa organization: Italian League for Research On Huntington (LIRH) Foundation – sequence: 5 givenname: Giuseppe surname: Curcio fullname: Curcio, Giuseppe organization: Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila – sequence: 6 givenname: Ferdinando surname: Squitieri fullname: Squitieri, Ferdinando organization: Huntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo Della Sofferenza Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37432564$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtuFDEQhi0URB5wARbIEptsGvzstpcoIiRSJDZhbXna1RNHHntwdUfKLtfgepwET2YAiQUbl_XXVw_Vf0qOcslAyFvOPnDGho-4e0XHhOxYbzXrxAtywrVlnVSDOTr8uRnUMTlFvGeMccXlK3IsByWF7tUJebq9A_rgUwx-jiXTMtG5Kddzk3ymD1DxIG-WNMdtAopjglowIs2w1LLFx_GupLKOo08tWQFyzGv6fQHctcw-VqAx06slzy0xl_zz6QfSEBE8wmvycvIJ4c0hnpFvl59vL666m69fri8-3XSjFP3cGS2MtUHxIdiVFYrBINgU-lHrvudqJbnnXk_cBu6NVgJWYTKT5EGP06CZkWfkfN93W8vzam4TcYSUfIayoBOtSkllrGjo-3_Q-7LU3LZrlLHMKsl1o94dqGW1geC2NW58fXS_b9sAsQfGdi2sMP1BOHM769zeQNcMdM8Gut1suS_CBuc11L-z_1P1C0LOn8E |
Cites_doi | 10.1007/s10072-021-05141-1 10.7224/1537-2073.2017-011 10.3233/JHD-200418 10.1016/S1474-4422(10)70245-3 10.1016/j.jns.2012.06.024 10.1038/s41583-018-0053-9 10.1037/a0020937 10.1016/0022-3956(75)90026-6 10.3389/fneur.2019.00453 10.3389/FNEUR.2021.667420 10.3389/FNEUR.2021.719460 10.1016/j.cortex.2011.12.003 10.1155/2017/7404289 10.1016/j.parkreldis.2018.09.007 10.1016/j.ctrv.2012.05.002 10.1016/S2215-0366(16)30144-4 10.3233/JHD-210471 10.1016/j.msard.2018.11.019 10.3390/JPM12010064 10.1002/mds.25964 10.1191/1352458503ms861oa 10.1002/BRB3.2151 10.1016/S1474-4422(18)30294-1 10.1007/s00415-020-09730-6 |
ContentType | Journal Article |
Copyright | Fondazione Società Italiana di Neurologia 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2023. Fondazione Società Italiana di Neurologia. |
Copyright_xml | – notice: Fondazione Società Italiana di Neurologia 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2023. Fondazione Società Italiana di Neurologia. |
DBID | AAYXX CITATION NPM 3V. 7TK 7X7 7XB 88E 88G 8AO 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ K9- K9. M0R M0S M1P M2M PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PSYQQ Q9U 7X8 |
DOI | 10.1007/s10072-023-06950-2 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Consumer Health Database ProQuest Health & Medical Collection Medical Database Psychology Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest One Psychology PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1590-3478 |
EndPage | 4348 |
ExternalDocumentID | 37432564 10_1007_s10072_023_06950_2 |
Genre | Journal Article |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 123 199 1N0 2.D 203 29N 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 408 409 40D 40E 53G 5VS 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDBF ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABIVO ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSNA ACUDM ACUHS ACZOJ ADBBV ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADPHR ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD AZFZN AZQEC B-. B0M BA0 BDATZ BENPR BGNMA BKNYI BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EAD EAP EAS EBC EBD EBLON EBS EBX ECV EHN EIOEI EJD EMB EMK EMOBN EN4 ENC ENX EPAXT EPL EPS EPT ESBYG ESX F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ K9- KDC KOV KPH LAS LLZTM M0R M1P M2M M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PSYQQ PT4 PT5 Q2X QOR QOS Q~Q R89 R9I RIG ROL RPX RRX RSV S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC TUS U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z82 Z83 Z87 Z8O Z8V Z91 ZMTXR ZOVNA ~8M ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT NPM 7TK 7XB 8FK ABRTQ K9. PJZUB PKEHL PPXIY PQEST PQUKI Q9U 7X8 |
ID | FETCH-LOGICAL-c326t-852899d417d9b9240e720fd6c556614b31a1a5f19d1a8542ebdf8f31d5cf75083 |
IEDL.DBID | 7X7 |
ISSN | 1590-1874 1590-3478 |
IngestDate | Fri Jul 11 13:08:03 EDT 2025 Sat Aug 23 14:49:53 EDT 2025 Wed Feb 19 02:22:20 EST 2025 Tue Jul 01 00:41:56 EDT 2025 Fri Feb 21 02:41:50 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Cognitive screening Neuropsychology MSNQ Cognitive impairment Cognitive assessment |
Language | English |
License | 2023. Fondazione Società Italiana di Neurologia. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c326t-852899d417d9b9240e720fd6c556614b31a1a5f19d1a8542ebdf8f31d5cf75083 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-2665-231X |
PMID | 37432564 |
PQID | 2889094315 |
PQPubID | 27321 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_2854434892 proquest_journals_2889094315 pubmed_primary_37432564 crossref_primary_10_1007_s10072_023_06950_2 springer_journals_10_1007_s10072_023_06950_2 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-12-01 |
PublicationDateYYYYMMDD | 2023-12-01 |
PublicationDate_xml | – month: 12 year: 2023 text: 2023-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: Italy – name: Milano |
PublicationTitle | Neurological sciences |
PublicationTitleAbbrev | Neurol Sci |
PublicationTitleAlternate | Neurol Sci |
PublicationYear | 2023 |
Publisher | Springer International Publishing Springer Nature B.V |
Publisher_xml | – name: Springer International Publishing – name: Springer Nature B.V |
References | Zarotti, Dale, Eccles, Simpson (CR11) 2020; 9 Ross, Tabrizi (CR25) 2011; 10 Sathe, Ware, Levey, Neacy, Blumenstein, Noble, Mühlbäck, Rosser, Landwehrmeyer, Sampaio (CR18) 2021 Eccles, Craufurd, Smith (CR9) 2021; 10 Migliore, D’Aurizio, Curcio, Squitieri (CR5) 2019 Hutchinson, Hosking, Kichenadasse, Mattiske, Wilson (CR22) 2012; 38 Sejbæk, Blaabjerg, Sprogøe, Ravnborg (CR20) 2018; 20 Migliore, Curcio, Porcaro (CR24) 2019; 27 Migliore, Jankovic, Squitieri (CR3) 2019 Sonder, Mokkink, van der Linden, Polman, Uitdehaag (CR16) 2012; 320 Stout, Queller, Baker (CR13) 2014; 29 Benedict, Munschauer, Linn, Miller, Murphy, Foley, Jacobs (CR15) 2003; 9 Fusilli, Migliore, Mazza (CR1) 2018; 17 Trinkler, Cleret de Langavant, Bachoud-Lévi (CR4) 2013; 49 de Luca, Morella, Consoli, Fanelli, Thibert, Statt, Latham, Squitieri (CR2) 2021; 22 Stout, Paulsen, Queller (CR6) 2011; 25 Migliore, D’Aurizio, Maffi, Ceccarelli, Ristori, Romano, Castaldo, Mariotti, Curcio, Squitieri (CR8) 2021 Migliore, Landi, Proietti, D’Aurizio, Squitieri, Mataluni, Nicoletti, Curcio, Marfia (CR17) 2021; 42 Migliore, Ghazaryan, Simonelli (CR23) 2017 Martinez-Horta, Horta-Barba, Perez-Perez (CR14) 2020 Folstein, Folstein, McHugh (CR19) 1975; 12 van Lonkhuizen, Vegt, Meijer (CR21) 2021 Zarotti, Dale, Eccles, Simpson (CR10) 2022 Eddy, Parkinson, Rickards (CR7) 2016; 3 Kieburtz (CR12) 1996; 11 di Filippo, Portaccio, Mancini, Calabresi (CR26) 2018; 19 FJR Eccles (6950_CR9) 2021; 10 S Migliore (6950_CR23) 2017 T Sejbæk (6950_CR20) 2018; 20 AD Hutchinson (6950_CR22) 2012; 38 CA Ross (6950_CR25) 2011; 10 CM Eddy (6950_CR7) 2016; 3 C Fusilli (6950_CR1) 2018; 17 S Migliore (6950_CR3) 2019 JC Stout (6950_CR6) 2011; 25 N Zarotti (6950_CR11) 2020; 9 PJC van Lonkhuizen (6950_CR21) 2021 JM Sonder (6950_CR16) 2012; 320 JC Stout (6950_CR13) 2014; 29 MF Folstein (6950_CR19) 1975; 12 S Migliore (6950_CR24) 2019; 27 M di Filippo (6950_CR26) 2018; 19 N Zarotti (6950_CR10) 2022 RHB Benedict (6950_CR15) 2003; 9 S Sathe (6950_CR18) 2021 I Trinkler (6950_CR4) 2013; 49 S Migliore (6950_CR17) 2021; 42 S Migliore (6950_CR8) 2021 S Migliore (6950_CR5) 2019 K Kieburtz (6950_CR12) 1996; 11 A de Luca (6950_CR2) 2021; 22 S Martinez-Horta (6950_CR14) 2020 |
References_xml | – volume: 42 start-page: 4583 year: 2021 end-page: 4589 ident: CR17 article-title: Validity of the Italian multiple sclerosis neuropsychological screening questionnaire publication-title: Neurol Sci doi: 10.1007/s10072-021-05141-1 – volume: 20 start-page: 50 year: 2018 end-page: 54 ident: CR20 article-title: Reliability and validity of a Danish version of the multiple sclerosis neuropsychological screening questionnaire publication-title: Int J MS Care doi: 10.7224/1537-2073.2017-011 – volume: 22 start-page: 1 year: 2021 end-page: 13 ident: CR2 article-title: A novel triplet-primed PCR assay to detect the full range of trinucleotide CAG repeats in the Huntingtin gene ( HTT) publication-title: Int J Mol Sci – volume: 9 start-page: 231 year: 2020 end-page: 243 ident: CR11 article-title: Psychological interventions for people with Huntington’s disease: a call to arms publication-title: J Huntingtons Dis doi: 10.3233/JHD-200418 – volume: 10 start-page: 83 year: 2011 end-page: 98 ident: CR25 article-title: Huntington’s disease: from molecular pathogenesis to clinical treatment publication-title: Lancet Neurol doi: 10.1016/S1474-4422(10)70245-3 – volume: 320 start-page: 91 year: 2012 end-page: 96 ident: CR16 article-title: Validation and interpretation of the Dutch version of the multiple sclerosis neuropsychological screening questionnaire publication-title: J Neurol Sci doi: 10.1016/j.jns.2012.06.024 – volume: 19 start-page: 599 year: 2018 end-page: 609 ident: CR26 article-title: Multiple sclerosis and cognition: synaptic failure and network dysfunction publication-title: Nat Rev Neurosci doi: 10.1038/s41583-018-0053-9 – volume: 25 start-page: 1 year: 2011 end-page: 14 ident: CR6 article-title: Neurocognitive signs in prodromal Huntington disease publication-title: Neuropsychology doi: 10.1037/a0020937 – volume: 12 start-page: 189 year: 1975 end-page: 198 ident: CR19 article-title: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician publication-title: J Psychiatr Res doi: 10.1016/0022-3956(75)90026-6 – year: 2019 ident: CR3 article-title: Genetic counseling in Huntington’s disease: potential new challenges on horizon? publication-title: Front Neurol doi: 10.3389/fneur.2019.00453 – year: 2021 ident: CR18 article-title: Enroll-HD: an integrated clinical research platform and worldwide observational study for Huntington’s disease publication-title: Front Neurol doi: 10.3389/FNEUR.2021.667420 – year: 2021 ident: CR21 article-title: Study protocol for the development of a European eHealth platform to improve quality of life in individuals with Huntington’s disease and their partners (HD-eHelp Study): a user-centered design approach publication-title: Front Neurol doi: 10.3389/FNEUR.2021.719460 – volume: 49 start-page: 549 year: 2013 end-page: 558 ident: CR4 article-title: Joint recognition-expression impairment of facial emotions in Huntington’s disease despite intact understanding of feelings publication-title: Cortex doi: 10.1016/j.cortex.2011.12.003 – year: 2017 ident: CR23 article-title: Cognitive impairment in relapsing-remitting multiple sclerosis patients with very mild clinical disability publication-title: Behav Neurol doi: 10.1155/2017/7404289 – year: 2019 ident: CR5 article-title: Task-switching abilities in pre-manifest Huntington’s disease subjects publication-title: Parkinsonism Relat Disord doi: 10.1016/j.parkreldis.2018.09.007 – volume: 11 start-page: 136 year: 1996 end-page: 142 ident: CR12 article-title: Unified Huntington’s Disease Rating Scale: reliability and consistency publication-title: Huntington Study Group Mov Disord – volume: 38 start-page: 926 year: 2012 end-page: 934 ident: CR22 article-title: Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review publication-title: Cancer Treat Rev doi: 10.1016/j.ctrv.2012.05.002 – volume: 3 start-page: 1079 year: 2016 end-page: 1086 ident: CR7 article-title: Changes in mental state and behaviour in Huntington’s disease publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(16)30144-4 – volume: 10 start-page: 277 year: 2021 end-page: 291 ident: CR9 article-title: Experiences of mindfulness-based cognitive therapy for premanifest Huntington’s disease publication-title: J Huntingtons Dis doi: 10.3233/JHD-210471 – volume: 27 start-page: 344 year: 2019 end-page: 349 ident: CR24 article-title: Emotional processing in RRMS patients: dissociation between behavioural and neurophysiological response publication-title: Mult Scler Relat Disord doi: 10.1016/j.msard.2018.11.019 – year: 2022 ident: CR10 article-title: More than just a brain disorder: a five-point manifesto for psychological care for people with Huntington’s disease publication-title: J Pers Med doi: 10.3390/JPM12010064 – volume: 29 start-page: 1281 year: 2014 end-page: 1288 ident: CR13 article-title: HD-CAB: a cognitive assessment battery for clinical trials in Huntington’s disease 1,2,3 publication-title: Mov Disord doi: 10.1002/mds.25964 – volume: 9 start-page: 95 year: 2003 end-page: 101 ident: CR15 article-title: Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire publication-title: Mult Scler doi: 10.1191/1352458503ms861oa – year: 2021 ident: CR8 article-title: Cognitive and behavioral associated changes in manifest Huntington disease: a retrospective cross-sectional study publication-title: Brain Behav doi: 10.1002/BRB3.2151 – volume: 17 start-page: 986 year: 2018 end-page: 993 ident: CR1 article-title: Biological and clinical manifestations of juvenile Huntington’s disease: a retrospective analysis publication-title: Lancet Neurol doi: 10.1016/S1474-4422(18)30294-1 – year: 2020 ident: CR14 article-title: Utility of the Parkinson’s disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington’s disease publication-title: J Neurol doi: 10.1007/s00415-020-09730-6 – volume: 38 start-page: 926 year: 2012 ident: 6950_CR22 publication-title: Cancer Treat Rev doi: 10.1016/j.ctrv.2012.05.002 – volume: 320 start-page: 91 year: 2012 ident: 6950_CR16 publication-title: J Neurol Sci doi: 10.1016/j.jns.2012.06.024 – volume: 20 start-page: 50 year: 2018 ident: 6950_CR20 publication-title: Int J MS Care doi: 10.7224/1537-2073.2017-011 – volume: 11 start-page: 136 year: 1996 ident: 6950_CR12 publication-title: Huntington Study Group Mov Disord – volume: 10 start-page: 277 year: 2021 ident: 6950_CR9 publication-title: J Huntingtons Dis doi: 10.3233/JHD-210471 – year: 2017 ident: 6950_CR23 publication-title: Behav Neurol doi: 10.1155/2017/7404289 – volume: 9 start-page: 231 year: 2020 ident: 6950_CR11 publication-title: J Huntingtons Dis doi: 10.3233/JHD-200418 – volume: 49 start-page: 549 year: 2013 ident: 6950_CR4 publication-title: Cortex doi: 10.1016/j.cortex.2011.12.003 – year: 2021 ident: 6950_CR18 publication-title: Front Neurol doi: 10.3389/FNEUR.2021.667420 – year: 2020 ident: 6950_CR14 publication-title: J Neurol doi: 10.1007/s00415-020-09730-6 – year: 2022 ident: 6950_CR10 publication-title: J Pers Med doi: 10.3390/JPM12010064 – volume: 10 start-page: 83 year: 2011 ident: 6950_CR25 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(10)70245-3 – volume: 29 start-page: 1281 year: 2014 ident: 6950_CR13 publication-title: Mov Disord doi: 10.1002/mds.25964 – volume: 12 start-page: 189 year: 1975 ident: 6950_CR19 publication-title: J Psychiatr Res doi: 10.1016/0022-3956(75)90026-6 – volume: 19 start-page: 599 year: 2018 ident: 6950_CR26 publication-title: Nat Rev Neurosci doi: 10.1038/s41583-018-0053-9 – year: 2019 ident: 6950_CR3 publication-title: Front Neurol doi: 10.3389/fneur.2019.00453 – volume: 42 start-page: 4583 year: 2021 ident: 6950_CR17 publication-title: Neurol Sci doi: 10.1007/s10072-021-05141-1 – volume: 17 start-page: 986 year: 2018 ident: 6950_CR1 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(18)30294-1 – volume: 25 start-page: 1 year: 2011 ident: 6950_CR6 publication-title: Neuropsychology doi: 10.1037/a0020937 – year: 2021 ident: 6950_CR21 publication-title: Front Neurol doi: 10.3389/FNEUR.2021.719460 – year: 2021 ident: 6950_CR8 publication-title: Brain Behav doi: 10.1002/BRB3.2151 – volume: 9 start-page: 95 year: 2003 ident: 6950_CR15 publication-title: Mult Scler doi: 10.1191/1352458503ms861oa – volume: 3 start-page: 1079 year: 2016 ident: 6950_CR7 publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(16)30144-4 – year: 2019 ident: 6950_CR5 publication-title: Parkinsonism Relat Disord doi: 10.1016/j.parkreldis.2018.09.007 – volume: 22 start-page: 1 year: 2021 ident: 6950_CR2 publication-title: Int J Mol Sci – volume: 27 start-page: 344 year: 2019 ident: 6950_CR24 publication-title: Mult Scler Relat Disord doi: 10.1016/j.msard.2018.11.019 |
SSID | ssj0001413 |
Score | 2.3547459 |
Snippet | Introduction
Multiple sclerosis neuropsychological questionnaire (MSNQ) is a brief questionnaire useful for screening patient’s and informant’s self-perception... Multiple sclerosis neuropsychological questionnaire (MSNQ) is a brief questionnaire useful for screening patient's and informant's self-perception of cognitive... IntroductionMultiple sclerosis neuropsychological questionnaire (MSNQ) is a brief questionnaire useful for screening patient’s and informant’s self-perception... Multiple sclerosis neuropsychological questionnaire (MSNQ) is a brief questionnaire useful for screening patient's and informant's self-perception of cognitive... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 4343 |
SubjectTerms | Adaptability Cognitive ability Huntington's disease Huntingtons disease Medicine Medicine & Public Health Multiple sclerosis Neurology Neuropsychology Neuroradiology Neurosciences Neurosurgery Original Article Psychiatry Questionnaires |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT8MwDI7QkBAXxJvCQEHiBpGaLK8eJ8Q0kMaJSbtVbZNIu3QT7Tjvb_D3-CU4fWxDgwPXpnWtfI7txI6N0B2IEAUzrwhLNSc8UY5onQnCnGBgEK0OrT_vGL3K4Zi_TMSkuRRWtNnubUiy0tQbl91CxQjYGBLKSIQEFO-u8Ht3kOIx66_0L-VVU2Sw0z5qqXhzVeZ3Gj_N0ZaPuRUfrczO4BAdNP4i7tcAH6Edmx-jvVETET9BS8AZg7RM695IeOYwuHT4uazOL_BHfRzmH7epg7gAQsDMtMBVMcv5pgqEQZ-IA6zgikX4Nk9AK-Jpjod1VwlwFr-WnwVuQjunaDx4ensckqarAsnAVSuJFn6PZThVJkph9wVgsNAZmQnhbXXaowlNhKORoYkWnNnUOO161IjMKV88_gx18lluLxCW0kmjlXWK9bgySQQIK-qolYxlMkoDdN9Objyvi2fE6zLJHooYoIgrKGIWoG47_3GzkIqYaR355EcqAnS7GoYl4OMaSW5nC_-OL-LHdQQkzmvcVr_rgYcEXh0P0EML5Jr437xc_u_1K7Tv29DXaS5d1CnfF_YanJUyvalk8xsC0OEJ priority: 102 providerName: Springer Nature |
Title | The validation of the Italian version of multiple sclerosis neuropsychological screening questionnaire in Huntington’s disease |
URI | https://link.springer.com/article/10.1007/s10072-023-06950-2 https://www.ncbi.nlm.nih.gov/pubmed/37432564 https://www.proquest.com/docview/2889094315 https://www.proquest.com/docview/2854434892 |
Volume | 44 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fb9MwED-NTUK8IBj_CmPyJN7AInbt2HlCLbTrQJsQolJ5ipLYlvqSFtLxvK_B1-OTcJc4LdO0PVmKE-fk39l3vjvfAbxBFhIo5g2XpVVcFSZwayvNZdASBaK3iSd7x_lFOpurzwu9iAa3JoZV9ntiu1G7VUU28vfS2oyi4IT-sP7JqWoUeVdjCY17cECpyyikyyy2By6KYWwD7HVG_kuj4qWZeHUuMZKjxOJJmumEy-uC6Ya2ecNT2gqg6SN4GDVHNuqgfgx7vj6E--fRN_4ErhBxhnyz7KoksVVgqNyxs01ryWC_O8MYPe6DCFmDAyExy4a1aS3X_2-G2EkhOUgKa0nEb-sC90e2rNmsqy-BauPfqz8Ni06epzCfTr5_nPFYX4FXqLRtuNV02nJKGJeVeA5DWGQSXFppTVK7HIpCFDqIzInCaiV96YINQ-F0FQylkX8G-_Wq9i-ApWlInTU-GDlUxhUZYm1EED6VskqzcgBv-8nN110ajXyXMJmgyBGKvIUilwM46uc_j0uqyXcMMICTbTcuBvJwFLVfXdI7lM5P2QyHeN7htv3dEHUl1O_UAN71QO4Gv52Wl3fT8goeUAH6LsDlCPY3vy79a1RTNuVxy4vHcDAafxpPqT398WWC7Xhy8fUb9s7l6B-UAunJ |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VrQRcEP8stGAkOIFF7Nixc0CIQqtd2l0h1Eq9pUlsS3vJLmQL4tbX4CV4qD5JZ_KzC6rg1utm44w8n2c-e8YzAC8QQgLdvOGysIqr3ARubam5DFqiQ_Q28nTeMZkmoyP16Vgfb8Dv_i4MpVX2NrEx1G5e0hn5G2ltSllwQr9bfOXUNYqiq30LjRYW-_7nD9yy1W_HH1G_L6Xc2z38MOJdVwFeIlVZcqtpj-GUMC4tcPeBwsgouKTUmnxVEYtc5DqI1IncaiV94YINsXC6DIaKp-O412BTxbiVGcDmzu7085eV7ReqaciMHIEipkZ113S6y3qRkRx9JI-SVEdc_u0KL_HbS7HZxuXt3YZbHVdl71tw3YENX92F65MuGn8PzhBjDJE6a_sysXlgSCfZeNmcnbDv7VEc_dynLbIaB0JhZjVrCmku_jS_-JCSgFAU1oiI71Y5WmQ2q9io7WiBRPX87FfNurDSfTi6krl_AINqXvlHwJIkJM4aH4yMlXF5iugyIgifSFkmaTGEV_3kZou2cEe2LtFMqshQFVmjikwOYauf_6xbxHW2htwQnq8e4_KjmEpe-fkp_YcKCCqb4hAPW72tPhcjO0NGqYbwulfkevB_y_L4_7I8gxujw8lBdjCe7j-Bm5IA1aTXbMFg-e3UbyNJWhZPO2QyOLnqxXABKX4hTg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VIlVcEP9dKGAkOIHV2LFj54AQoqx2Ka04UGlvIYltaS_ZhWxB3PoavEofp0_CjJPsgiq49RonzsjzjWc8M54BeI4QEqjmDZeVVVyVJnBra81l0BIVoreJJ3_H0XE2OVEfZnq2BefDXRhKqxz2xLhRu0VNPvJ9aW1OWXBC74c-LeLTwfjN8iunDlIUaR3aaXQQOfQ_f-DxrX09PUBev5By_P7zuwnvOwzwGs2WFbeazhtOCePyCk8iSJhMgstqrUlvVakoRamDyJ0orVbSVy7YkAqn62CokDrOew2um1QLkjEzWx_2KH8yJvfrnGKnRvUXdvpre4mRHLUlT7JcJ1z-rRQvWbqXorRR-Y1vwc3eamVvO5jdhi3f3IGdoz4ufxfOEG0MMTvvOjSxRWBoWLLpKnpR2PfOKUePhwRG1uJESMy8ZbGk5vLPjRgHKR0ISWGRRPy2KXFvZvOGTbreFmiyXpz9alkfYLoHJ1ey8vdhu1k0fhdYloXMWeODkakyrswRZ0YE4TMp6yyvRvByWNxi2ZXwKDbFmokVBbKiiKwo5Aj2hvUvenFuiw34RvBsPYyCSNGVsvGLU3qHSgkqm-MUDzq-rX-Xop2GtqUawauBkZvJ_03Lw__T8hR2UASKj9Pjw0dwQxKeYp7NHmyvvp36x2gtraonEZYMvly1HPwGmoUkHg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+validation+of+the+Italian+version+of+multiple+sclerosis+neuropsychological+screening+questionnaire+in+Huntington%27s+disease&rft.jtitle=Neurological+sciences&rft.au=Migliore%2C+Simone&rft.au=D%27Aurizio%2C+Giulia&rft.au=Ceccarelli%2C+Consuelo&rft.au=Casella%2C+Melissa&rft.date=2023-12-01&rft.eissn=1590-3478&rft_id=info:doi/10.1007%2Fs10072-023-06950-2&rft_id=info%3Apmid%2F37432564&rft.externalDocID=37432564 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1590-1874&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1590-1874&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1590-1874&client=summon |